SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,685 | -8.3% | 714 | 0.0% | 0.14% | -8.6% |
| Q2 2023 | $21,463 | -17.0% | 714 | 0.0% | 0.15% | -16.5% |
| Q1 2023 | $25,868 | -92.2% | 714 | -91.5% | 0.18% | +5966.7% |
| Q4 2017 | $333,000 | -8.3% | 8,355 | -7.8% | 0.00% | -25.0% |
| Q3 2017 | $363,000 | -12.5% | 9,064 | -5.9% | 0.00% | 0.0% |
| Q2 2017 | $415,000 | +33.9% | 9,628 | -2.9% | 0.00% | +33.3% |
| Q1 2017 | $310,000 | +1048.1% | 9,915 | +296.9% | 0.00% | – |
| Q2 2014 | $27,000 | – | 2,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |